Expansion or contraction of stenting in coronary artery disease?

Affiliations

¹ Department of Cardiac Surgery, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK. Electronic address: david.taggart@ouh.nhs.uk.
² Department of Cardiothoracic Surgery, University Hospital Birmingham, University of Birmingham, Birmingham, UK.

Comment

David P Taggart et al. Lancet. 2019.

. 2019 Oct 12;394(10206):1299-1300.

doi: 10.1016/S0140-6736(19)32040-9. Epub 2019 Sep 2.

¹ Department of Cardiac Surgery, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK. Electronic address: david.taggart@ouh.nhs.uk.
² Department of Cardiothoracic Surgery, University Hospital Birmingham, University of Birmingham, Birmingham, UK.

No abstract available

Comment on

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Holmes DR Jr, Curzen N, Davierwala P, Noack T, Milojevic M, Dawkins KD, da Costa BR, Jüni P, Head SJ; SYNTAX Extended Survival Investigators. Thuijs DJFM, et al. Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2. Lancet. 2019. PMID: 31488373 Clinical Trial.